Wednesday - ARVO

4914 – 4934 – Wednesday – Posters
Wednesday Posters
11:00 am – 12:45 pm
4914 — D0353 Reproducibility and
Agreeability of Automated Retinal
Pigment Epithelial Detachment Volumetric
Measurements via Spectral Domain Optical
Coherence Tomography. Joseph Ho 1 , M. Adhi 1 , E.
Cole 1 , J. J. Liu 2 , J. G. Fujimoto 2 , J. S. Duker 1 , N.
K. Waheed 1 . 1 Department of Ophthalmology, Tufts-
New England Eye Center, Boston, MA; 2 Research
Laboratory of Electronics, Massachusetts Institute
of Technology, Cambridge, MA *CR
4915 — D0354 Use of SD-OCT/SLO as an
alternative to ultrasonography to monitor
patients with recurrent retinal detachments
and silicone oil tamponade. Jessica N. Taibl 1, 2 ,
S. I. Sayegh 1 . 1 The EYE Center, Champaign, IL;
2
University of Illinois, Urbana-Champaign, IL
4916 — D0355 Long-term changes of
fudus autofluorescence in central serous
chorioretinopathy. Tetsuju Sekiryu, H. Oyamada,
K. Imaizumi, T. Mori, I. Maruko. Ophthalmology,
Fukushima Medical University, Fukushima, Japan
Exhibit Hall D0356-D0376
Wednesday, May 08, 2013 11:00 AM-12:45 PM
Retina
447 DME: OCT and Function
Moderators: Masahiko Shimura and
Francesco Bandello
4917 — D0356 Correlations between Retinal
Morphological Changes and Concentrations of
Cytokines in Eyes with Diabetic Macular Edema.
Shozo Sonoda, T. Yamashita, M. Shirasawa, H.
Otsuka, Y. Sonoda, T. Sakamoto. Department of
Ophthalmology, Kagoshima University, Kagoshima,
Japan
4918 — D0357 Correlation between Diabetic
Macular Edema (DME) and extraocular
complications observed during diabetes.
Olivier Lichtwitz 1 , N. Leveziel 1 , M. Boissonnot 1 ,
A. Miot 2 , X. Piguel 2 , F. Torremocha 2 , P. Saulnier 3 ,
R. Maréchaud 2 , S. Hadjadj 2 . 1 Ophthalmology,
Hospital University of Poitiers, Poitiers, France;
2
Endocrinollogy, Hospital University of Poitiers,
Poitiers, France; 3 Center of Clinical Investigation,
INSERM CIC 802, Poitiers, France *CR
4919 — D0358 Evaluation of choroidal
thickness by enhanced depth imaging OCT in
the LUCIDATE study: a randomised clinical
trial to compare outcomes of ranibizumab
with laser in diabetic macular oedema. Rishma
Gohil 1, 2 , O. Comyn 1 , P. A. Keane 1 , P. J. Patel 1 , J. W.
Bainbridge 1 , S. Sivaprasad 1, 2 , P. G. Hykin 1 . 1 NIHR
Biomedical Research Centre at Moorfields Eye
Hospital NHS Foundation Trust and UCL Institute
of Ophthalmology, London, United Kingdom;
2
King’s College London, London, United Kingdom
*CR, f
4920 — D0359 Chromatic sensitivity in
diabetic patients treated with Ozurdex. Ahmed
F. Abdel-hay 1, 2 , S. Sivaprasad 1 , A. Subramanian 2 ,
E. Konstantakopoulou 2 , D. F. Edgar 2 , J. L. Barbur 2 .
1
Ophthalmology, King’s College Hospital, London,
United Kingdom; 2 1Applied Vision Research
Centre, City University London, London, United
Kingdom *CR, f
4921 — D0360 Longitudinal Comparison of
Visual Acuity as Measured by ETDRS Chart and
by Potential Acuity Meter in Eyes with Macular
Edema and Its Relationship with Macular
Sensitivity and Thickness. Elham Hatef Naimi 1, 2 ,
M. Hanout 1 , O. O. Agbedia 1 , A. Moradi 1 , D. V.
Do 1 , D. L. Guyton 1 , Q. Nguyen 1 . 1 Ophthalmology,
Wilmer Eye Inst, Johns Hopkins Univ, Baltimore,
MD; 2 General Preventive Medicine, Johns Hopkins
Bloomberg School of Public Health, Baltimore,
MD *CR
4922 — D0361 Retinal Perifoveal Inner
Layer Disorganization as a Predictor of Visual
Acuity Outcomes in Eyes with Center-involved
Diabetic Macular Edema. Michael M. Lin 1, 7 , R.
Sarangi 1, 2 , J. Lammer 1, 3 , A. Y. Ganjei 1 , S. Radwan 4,
5
, A. Z. Soliman 4, 5 , P. S. Silva 1, 6 , L. P. Aiello 1,
6
, J. K. Sun 1, 6 . 1 Beetham Eye Institute, Joslin
Diabetes Center, Boston, MA; 2 Boston University
School of Medicine, Boston, MA; 3 Department
of Ophthalmology and Optometry, Medical
University Vienna, Vienna, Austria; 4 Department
of Ophthalmology, University of Minnesota,
Minneapolis, MN; 5 Department of Ophthalmology,
Cairo University, Cairo, Egypt; 6 Department of
Ophthalmology, Harvard Medical School, Boston,
MA; 7 Harvard Medical School, Boston, MA *CR
4923 — D0362 The effect of hard exudates
and epiretinal fibrosis on the retinal thickness
as calculated by optical coherence tomography
(OCT) in diabetic macular edema. Delila Hodzic 1 ,
B. A. Sander 1 , H. Lund-Andersen 1, 2 . 1 Department
of ophthalmology, Glostrup Hospital, Glostrup,
Denmark; 2 Faculty of Health Sciences, University
of Copenhagen, Copenhagen, Denmark
4924 — D0363 Correlation of structural and
visual function tests in patients with diabetic
macular edema. Elizabeth Pearce, R. Mathew, A.
F. Abdel-hay, S. Sivaprasad. Ophthalmology, King’s
College Hospital, London, United Kingdom *CR, f
4925 — D0364 Retinal Layer Thicknesses
in SDOCT Images for Diabetics with Hard
Exudates. Joel A. Papay 1 , A. E. Elsner 1 , C. A.
Clark 1 , V. Malinovsky 1 , S. G. Brahm 1 , S. B. Young 1 ,
A. V. Walker 1 , T. V. Litvin 2 , G. Y. Ozawa 2 , J. A.
Cuadros 2 . 1 School of Optometry, Indiana University,
Bloomington, IN; 2 School of Optometry, UC
Berkeley, Berkeley, CA *CR
4926 — D0365 Retinal thickness reduction
and layers involvement in different diseases
visualized by SD-OCT. Michele M. Iester 1 , L.
Borgia 2 . 1 DiNOGMI, University of Genoa, Genova,
Italy; 2 Is.Pre Oftalmica, Genoa, Italy
4927 — D0366 Visual acuity evaluation in
patients treated with ranibizumab for diabetic
macular edema. Marc Stahel 1 , P. P. Ciechanowski 1 ,
F. Moser 1 , S. Lortz 1 , H. M. Fassnacht 1 , N. T. Graf 2 ,
M. D. Becker 1 , S. Michels 1 . 1 Ophthalmology,
Triemli Hospital Zurich, Zurich, Switzerland; 2 Graf
Biostatistics, Winterthur, Switzerland *CR
4928 — D0367 Differences in the topographic
profile of retinal thickening in cases of diabetic
macular edema with and without serous
macular detachment. Hannah Shereef 1, 4 , O.
Comyn 2 , S. Sivaprasad 2 , P. G. Hykin 2 , G. C.
Cheung 3 , N. Narendran 4 , Y. C. Yang 4 . 1 University
of Birmingham, Birmingham, United Kingdom;
2
National Institute for Health Research Biomedical
Research Centre at Moorfields Eye Hospital
NHS Foundation Trust and UCL Institute of
Ophthalmology, London, United Kingdom;
3
Singapore National Eye Centre, Singapore,
Singapore; 4 Royal Wolverhampton Hospitals NHS
Trust, Wolverhampton, United Kingdom *CR
4929 — D0368 Use of a Retinal Acuity Meter
(RAM) and Brightness Acuity Meter (BAM) to
Identify Early Diabetic Macular Edema. Albert
Li, D. J. Sackel, A. Chen, L. Park. Ophthalmology,
NYU School of Medicine, New York, NY
4930 — D0369 Optimal treatment strategy
for Stage 5 Type 2A Idiopathic Macular
Telangiectasia with anti-vascular endothelial
growth factor (VEGF) agents - When to stop?
Sharad S. Malavade, S. Cohen. Ophthalmology,
University of South Florida, Tampa, FL
4931 — D0370 Safety, sterility and stability of
direct- from- vial multiple dosing intravitreal
injection of bevacizumab. Taraprasad Das 1 , S.
Volety 2 , S. M. Ahsan 2 , A. K. Thakur 2 , S. Sharma 1 ,
S. Basu 1 , T. R. Padhi 1 , M. Rao 2 . 1 Retina Vitreous
Services, LV Prasad Eye Institute, Bhubaneswar,
India; 2 Center for Cellular and Molecular Biology,
Hyderabad, India
4932 — D0371 Increased Healthcare Cost
Related To Adding Dexamethasone Implant
(Ozurdex ® ) To Bevacizumab (Avastin ® )
Monotherapy In Patients With Cystoid Macular
Edema (CME) Due To Retinal Vein Occlusion
(RVO) May Be Balanced By Less Frequent
Follow-Up. Omar Saleh, J. Heroman, S. Schaal.
University of Louisville, Louisville, KY
4933 — D0372 Reperfusion of ischemia with
central retinal vein occlusion by activated
protein C. Motohiro Kamei, N. Matsumura, M.
Suzuki, S. Sakimoto, H. Sakaguchi, K. Nishida.
Ophthalmology, Osaka Univ Grad School of
Medicine, Suita, Japan *CR, f
4934 — D0373 The Efficacy of Single
Intravitreal Ranibizumab Injection in Acute
Nonarteritic Ischemic Optic Neuropathy. Ali
Osman Saatci, O. Taskin, O. Barut Selver, A. Yaman,
M. Soylev Bajin. Ophthalmology Department,
Dokuz Eylul University, Izmir, Turkey
The Commercial Relationships (CR) Index for Disclosures and the Clinical Trial (CT) Registration Index are at arvo.org/2013/ProgramSummary/Index.
314